Yingwei Xue
- Topics
- Cancer Immunotherapy and Biomarkers (7 papers)Inflammatory Biomarkers in Disease Prognosis (7 papers)Cancer-related molecular mechanisms research (4 papers)
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- BioMed Research InternationalOxidative Medicine and Cellular LongevityBiomedicine & Pharmacotherapy
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Yingwei Xue
27 papers receiving 405 citations
Peers
Comparison fields: 5 of 63
- Molecular Biology 195
- Oncology 149
- Cancer Research 121
- Immunology 85
- Pulmonary and Respiratory Medicine 76
Countries citing papers authored by Yingwei Xue
This map shows the geographic impact of Yingwei Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingwei Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingwei Xue more than expected).
Fields of papers citing papers by Yingwei Xue
This network shows the impact of papers produced by Yingwei Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingwei Xue. The network helps show where Yingwei Xue may publish in the future.
Co-authorship network of co-authors of Yingwei Xue
This figure shows the co-authorship network connecting the top 25 collaborators of Yingwei Xue. A scholar is included among the top collaborators of Yingwei Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingwei Xue. Yingwei Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 5 | |
| 5 | 7 | |
| 6 | 7 | |
| 7 | 4 | |
| 8 | 2 | |
| 9 | 11 | |
| 10 | 37 | |
| 11 | 5 | |
| 12 | 17 | |
| 13 | 9 | |
| 14 | 34 | |
| 15 | 3 | |
| 16 | 14 | |
| 17 | 77 | |
| 18 | 14 | |
| 19 | 27 | |
| 20 | [Reversal effect and mechanism of arsenic trioxide on multidrug resistance of gastric carcinoma cells SGC7901]. | 3 |
About Yingwei Xue
Yingwei Xue is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 27 papers that have together received 406 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Inflammatory Biomarkers in Disease Prognosis (7 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Cancer Research (121 citations), Oncology (149 citations) and Immunology (85 citations). Yingwei Xue has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Chunfeng Li, Junqiang Qiu, Chunfeng Li, Man Li, Hongyu Gao, Sen Li, Lina Quan, Chunyan Yang, Xiuwen Lan and Xiliang Cong. Their work appears in journals such as BioMed Research International, Oxidative Medicine and Cellular Longevity and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.